SCHEMBL23218756

SCHEMBL23218756

COC(=O)Cc1cccc(C(=O)NOCc2coc3ccc(-c4cccc(CN)c4)cc23)c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CFD P00746 6/20 0.51
F11 P03951 2/20 0.40
TPSB2 P20231 2/20 0.40
LOXL2 Q9Y4K0 1/20 0.40
SUCNR1 Q9BXA5 1/20 0.40
F10 P00742 5/20 0.38
PRSS1 P07477 4/20 0.38
ROCK2 O75116 1/20 0.37
F2 P00734 2/20 0.37
RAB9A P51151 1/20 0.36
FFAR1 O14842 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
PLG P00747 1/20 0.36
PLAU P00749 1/20 0.36
KLKB1 P03952 1/20 0.36
F7 P08709 1/20 0.36
NQO2 P16083 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29852740 0.84 CFD (0.50) CFDF11TPSB2FFAR1MTNR1A
SCHEMBL23218206 0.84 CFD (0.50) CFDF11TPSB2FFAR1MTNR1A
SCHEMBL29852668 0.77 CFD (0.45) CFDF11TPSB2SUCNR1FFAR1
SCHEMBL23218403 0.77 CFD (0.45) CFDF11TPSB2SUCNR1FFAR1
SCHEMBL28736109 0.76 CFD (0.44) CFDF11TPSB2SUCNR1FFAR1
SCHEMBL29853127 0.76 CFD (0.44) CFDF11TPSB2SUCNR1FFAR1
SCHEMBL23218518 0.74 CFD (0.61) CFDF11TPSB2FFAR1PLG
SCHEMBL29591826 0.74 CFD (0.61) CFDF11TPSB2FFAR1PLG
SCHEMBL23218306 0.73 CFD (0.46) CFDF11TPSB2LOXL2RAB9A
SCHEMBL29852729 0.73 CFD (0.46) CFDF11TPSB2LOXL2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed